AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$AMBQ

Hanson Scott McLean sold $604K of AMBQ

Hanson Scott McLean (Chief Technology Officer) sold 8,680 shares of Ambiq Micro, Inc. (AMBQ) at an average of $69.60 ($69.11–$71.86, $0.60M total) across 3 trades on 2026-10-02.

Original reporting
SEC EDGAR · Hanson Scott McLean
Published Oct 6, 2026, 10:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 10:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$AMBQ
Bearish
medium confidence
Mentioned
$AMBQ
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQBearishLow
01

Why it matters

The disclosed sale provides fresh, primary‑source information about insider activity, but the monetary amount is modest.

02

Market read

A routine insider sale with limited material impact; may cause slight short‑term price pressure.

03

What to watch

No accompanying earnings or guidance change; the market may already price in insider activity.

Relevance 5/10Novelty 4/10Timing: post‑market filing on 2026‑10‑06

Background

SEC Form 4 filing discloses insider transactions required by regulation.

Company-level read

Ticker impact

$AMBQBearishMedium confidence
Context

Chief Technology Officer Hanson Scott McLean sold 8,680 shares for $604K via open‑market transactions on 2026‑10‑02.

Expected impact

likely downward pressure as the market prices in the insider sell.

Evidence & confidence

The sale size is modest but the insider is a senior executive; such transactions often trigger short‑term selling pressure.

Market effects

Sector

Minimal impact on the broader semiconductor sector.

Regional

Limited to U.S. investors tracking Ambiq Micro.

Global

Low; the filing does not affect global markets.

Counterpoint

What could challenge this read

The sale could be a routine portfolio rebalancing rather than a negative signal.

Key entities

  • Company
    Ambiq Micro, Inc.

    Semiconductor company listed on NASDAQ under ticker AMBQ.

  • Individual
    Hanson Scott McLean

    Chief Technology Officer of Ambiq Micro.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AMBQ insider trading history →

Related articles

$AMBQMed

Ambiq Q3 2026 slides: 110% revenue growth, margins expand to 48.7%

Ambiq Micro (AMBQ) reported Q3 2026 revenue growth of 110% YoY to $38.1M, with gross margins expanding to 48.7%. The company expects similar growth in Q4 and full-year sales of ~$140M. Despite beating earnings expectations, shares fell 4.09% premarket, reflecting investor concerns about profitability and execution risks. Ambiq highlighted its edge AI semiconductor business and product pipeline, including the upcoming Atomiq platform.

investing.com
$AMBQMed

Ambiq Reports Third Quarter 2026 Financial Results

Ambiq Micro, Inc. (AMBQ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ambiq Reports Third Quarter 2026 Financial Results Third quarter net sales increased 110% year-over-year on broad demand across customers, product families and form factors Gross profit more than doubled year-over-year, outpacing net sales growth Expect fourth quarter net sales o

SEC EDGAR 8-K
$AMBQMed

Jefferies initiates Ambiq Micro stock with buy rating on AI edge computing potential

Jefferies initiated coverage on Ambiq Micro (NYSE: AMBQ) with a buy rating and $90 price target, citing its AI edge computing potential. The company's SPOT architecture offers power advantages for edge devices. Ambiq Micro reported 89.7% revenue growth in Q2, with full-year sales outlook raised to $135 million. Several analysts revised earnings upwards, and multiple firms increased price targets.

investing.com
Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

yahoo.com
Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

businesstimes.com.sg